Cyberonics, Inc.

Cyberonics, Inc. is a medical technology company specialized in the development and commercialization of neuromodulation therapies for individuals with epilepsy and other neurological disorders. With an emphasis on vagus nerve stimulation (VNS), their innovative solutions aim to improve the quality of life for patients suffering from drug-resistant epilepsy and treatment-resistant depression. For over 30 years, Cyberonics has been at the forefront of neuromodulation advancements, leveraging cutting-edge science and robust clinical research to provide healthcare professionals with reliable, safe, and efficacious treatment options.